title: Deep brain stimulation for camptocormia in dystonia and Parkinson's disease.
abstract: Camptocormia, or "bent spine syndrome", may occur in various movement disorders such as primary dystonia or idiopathic Parkinson's disease (PD). Although deep brain stimulation (DBS) is an established treatment in refractory primary dystonia and advanced PD, few data are available on the effect of DBS on camptocormia comparing these two conditions. Seven patients (4 with dystonia, 3 with PD; mean age 60.3 years at surgery, range 39-73 years) with camptocormia were included in the study. Five patients underwent bilateral GPi DBS and two patients underwent bilateral STN DBS guided by CT-stereotactic surgery and microelectrode recording. Pre- and postoperative motor assessment included the BFM in the dystonia patients and the UPDRS in the PD patients. Severity of camptocormia was assessed by the BFM subscore for the trunk at the last available follow-up at a mean of 17.3 months (range 9-36 months). There were no surgical complications. In the four patients with dystonia there was a mean improvement of 53% in the BFM motor score (range 41-79%) and of 63% (range 50-67%) in the BFM subscore for the trunk at the last available follow-up (mean 14.3 months, range 9-18 months). In the three patients with camptocormia in PD who underwent bilateral STN DBS (2 patients) or pallidal DBS (1 patient), the PD symptoms improved markedly (mean improvement in the UPDRS motor subscore stimulation on/medication off 55%, range 49-61%), but there was no or only mild improvement of camptocormia in the two patients who underwent STN DBS, and only moderate improvement in the patient with GPi DBS at the last available follow-up (mean 21 months, range 12-36 months). GPi DBS is an effective treatment for camptocormia in dystonia. The response of camptocormia to chronic STN or GPi DBS in PD is more heterogenous. The latter may be due to a variety of causes and needs further clarification.
authors.affiliation: Department of Neurosurgery, Medical School Hannover, MHH, Carl-Neuberg-Straße 1, 30652, Hannover, Germany.
authors.forename: Hans-Holger
authors.initials: HH
authors.lastname: Capelle
authors.forename: Christoph
authors.initials: C
authors.lastname: Schrader
authors.forename: Christian
authors.initials: C
authors.lastname: Blahak
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Fogel
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Kinfe
authors.forename: Hansjoerg
authors.initials: H
authors.lastname: Baezner
authors.forename: Joachim K
authors.initials: JK
authors.lastname: Krauss
mesh_terms: D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D046690:Deep Brain Stimulation; D004421:Dystonia / Q000150:complications / Q000628:therapy*; D004567:Electrodes, Implanted; D005260:Female; D005917:Globus Pallidus / Q000502:physiology; D006801:Humans; D017116:Low Back Pain / Q000209:etiology / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009134:Muscular Atrophy, Spinal / Q000209:etiology / Q000601:surgery / Q000628:therapy; D019637:Orthopedic Procedures; D010147:Pain Measurement; D010300:Parkinson Disease / Q000150:complications / Q000628:therapy*; D013121:Spinal Curvatures / Q000209:etiology / Q000601:surgery / Q000628:therapy; D020531:Subthalamic Nucleus / Q000502:physiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents
references.citation: Stereotact Funct Neurosurg. 2009;87(6):379-84
references.pmid: 19844137
references.citation: Neuromodulation. 2009 Jan;12(1):8-21
references.pmid: 22151218
references.citation: J Neurol. 2006 Dec;253 Suppl 7:VII7-13
references.pmid: 17131231
references.citation: J Neurosurg. 2009 Feb;110(2):229-33
references.pmid: 18976055
references.citation: Acta Neurochir Suppl. 2006;99:25-8
references.pmid: 17370758
references.citation: J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1229-34
references.pmid: 16735399
references.citation: N Engl J Med. 2005 Feb 3;352(5):459-67
references.pmid: 15689584
references.citation: Parkinsonism Relat Disord. 2006 Sep;12(6):372-5
references.pmid: 16731023
references.citation: J Neurosurg. 2003 Apr;98(4):785-92
references.pmid: 12691403
references.citation: J Neurol. 2006 Dec;253 Suppl 7:VII14-16
references.pmid: 17131221
references.citation: Clin Rheumatol. 2008 Apr;27(4):525-7
references.pmid: 18087763
references.citation: Mov Disord. 2006 Nov;21(11):2008-10
references.pmid: 16972244
references.citation: J Neurosurg. 2005 Dec;103(6):1081-3
references.pmid: 16381196
references.citation: Eur J Neurol. 2003 Jan;10(1):107-8
references.pmid: 12535006
references.citation: Neurology. 2005 Aug 9;65(3):355-9
references.pmid: 16087897
references.citation: Mov Disord. 2001 Jan;16(1):177-80
references.pmid: 11215587
references.citation: Brain. 1998 Mar;121 ( Pt 3):451-7
references.pmid: 9549521
references.citation: J Neurol. 2008 Jun;255(6):881-4
references.pmid: 18338193
references.citation: Mov Disord. 2007 Oct 15;22(13):1974-5
references.pmid: 17712851
references.citation: Neurology. 2007 Aug 14;69(7):681-8
references.pmid: 17698790
references.citation: Neurophysiol Clin. 2008 Dec;38(6):459-65
references.pmid: 19026965
references.citation: Mov Disord. 2009 May 15;24(7):1076-9
references.pmid: 19353719
references.citation: J Neurosurg. 2002 Aug;97(2):461-6
references.pmid: 12186477
references.citation: Lancet. 1999 Sep 4;354(9181):837-8
references.pmid: 10485734
references.citation: Clin Rheumatol. 2007 Jun;26(6):1017-9
references.pmid: 16565891
references.citation: Stereotact Funct Neurosurg. 2009;87(1):37-44
references.pmid: 19174619
references.citation: Neurology. 2003 Jun 24;60(12):2017-8
references.pmid: 12821763
references.citation: J Neurol. 2007 Feb;254(2):169-78
references.pmid: 17334951